In this edition, NCI director announces breast cancer diagnosis, neoadjuvant chemotherapy regimen in pancreatic cancer, gender harassment is in oncology and more. Read the full coverage here: NCI director announces breast cancer diagnosis, says prognosis 'very favorable' Neoadjuvant chemotherapy regimen extends survival in pancreatic cancer Survey shows gender harassment is 'strikingly common' in oncology Proton pump inhibitor use linked to elevated cancer risk Memorial Sloan Kettering pauses CAR-T clinical trial to investigate patient death References: Katz MHG, et al. JAMA Oncol. 2022;doi:10.1001/jamaoncol.2022.2319. Press Release Press Release Subbiah IM, et al. J Clin Oncol. 2022;doi:10.1200/JCO.21.02574. Tran TH, et al. Abstract 1843. Presented at: World Cancer Congress; Oct. 18-20, 2022; Geneva.

Ver todos los episodios